CIK 1906594
China Universal Asset Management Co., Ltd.
Institutional 13F holdings & portfolio
Holdings
497
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
4
Holdings
13F filings as of Dec 31, 2025 · Showing 351–400 of 497
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| CSTL | CASTLE BIOSCIENCES INC | 5K | $100K–$500K | SH |
| PCRX | PACIRA BIOSCIENCES INC | 7K | $100K–$500K | SH |
| ANNX | ANNEXON INC | 36K | $100K–$500K | SH |
| URGN | UROGEN PHARMA LTD | 8K | $100K–$500K | SH |
| XNCR | XENCOR INC | 12K | $100K–$500K | SH |
| NVAX | NOVAVAX INC | 26K | $100K–$500K | SH |
| SANA | SANA BIOTECHNOLOGY INC | 43K | $100K–$500K | SH |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 65K | $100K–$500K | SH |
| TNDM | TANDEM DIABETES CARE INC | 8K | $100K–$500K | SH |
| GMED | GLOBUS MEDICAL INC - A | 2K | $100K–$500K | SH |
| ERAS | ERASCA INC | 46K | $100K–$500K | SH |
| PODD | INSULET CORP | 600 | $100K–$500K | SH |
| NTLA | INTELLIA THERAPEUTICS INC | 19K | $100K–$500K | SH |
| LI | LI AUTO INC - ADR | 10K | $100K–$500K | SH |
| PVLA | PALVELLA THERAPEUTICS INC | 2K | $100K–$500K | SH |
| ABCL | ABCELLERA BIOLOGICS INC | 49K | $100K–$500K | SH |
| DEO | DIAGEO PLC-SPONSORED ADR | 2K | $100K–$500K | SH |
| PRCT | PROCEPT BIOROBOTICS CORP | 5K | $100K–$500K | SH |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 17K | $100K–$500K | SH |
| ALMS | ALUMIS INC | 16K | $100K–$500K | SH |
| TBPH | THERAVANCE BIOPHARMA INC | 8K | $100K–$500K | SH |
| RAPT | RAPT THERAPEUTICS INC | 5K | $100K–$500K | SH |
| ABUS | ARBUTUS BIOPHARMA CORP | 31K | $100K–$500K | SH |
| BCAX | BICARA THERAPEUTICS INC | 9K | $100K–$500K | SH |
| CRMD | CORMEDIX INC | 13K | $100K–$500K | SH |
| ELVN | ENLIVEN THERAPEUTICS INC | 10K | $100K–$500K | SH |
| GOSS | GOSSAMER BIO INC | 48K | $100K–$500K | SH |
| KURA | KURA ONCOLOGY INC | 14K | $100K–$500K | SH |
| MESO | MESOBLAST LTD- SPON ADR | 8K | $100K–$500K | SH |
| ESPR | ESPERION THERAPEUTICS INC | 39K | $100K–$500K | SH |
| CRVS | CORVUS PHARMACEUTICALS INC | 18K | $100K–$500K | SH |
| GERN | GERON CORP | 104K | $100K–$500K | SH |
| VIR | VIR BIOTECHNOLOGY INC | 23K | $100K–$500K | SH |
| ON | ON SEMICONDUCTOR | 3K | $100K–$500K | SH |
| AVBP | ARRIVENT BIOPHARMA INC | 7K | $100K–$500K | SH |
| JANX | JANUX THERAPEUTICS INC | 10K | $100K–$500K | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 8K | $100K–$500K | SH |
| ORIC | ORIC PHARMACEUTICALS INC | 16K | $100K–$500K | SH |
| AQST | AQUESTIVE THERAPEUTICS INC | 20K | $100K–$500K | SH |
| GHRS | GH RESEARCH PLC | 10K | $100K–$500K | SH |
| RIGL | RIGEL PHARMACEUTICALS INC | 3K | $100K–$500K | SH |
| TECX | TECTONIC THERAPEUTIC INC | 6K | $100K–$500K | SH |
| PAHC | PHIBRO ANIMAL HEALTH CORP-A | 3K | $100K–$500K | SH |
| REPL | REPLIMUNE GROUP INC | 13K | $100K–$500K | SH |
| ARVN | ARVINAS INC | 10K | $100K–$500K | SH |
| TMDX | TRANSMEDICS GROUP INC | 1K | $100K–$500K | SH |
| ABSI | ABSCI CORP | 35K | $100K–$500K | SH |
| RGNX | REGENXBIO INC | 8K | $100K–$500K | SH |
| LXEO | LEXEO THERAPEUTICS INC | 12K | $100K–$500K | SH |
| CTMX | CYTOMX THERAPEUTICS INC | 28K | $100K–$500K | SH |